Navy Capital Archives - Green Market Report

Debra BorchardtOctober 28, 2019
1906.jpg

7min00

Denver-based 1906 closed on an $18 million in its most recent capital raise. The round was led by Navy Capital and included a range of institutions, high net worth individuals and 1906’s existing investors. 1906 said it will use the investment to fund the company’s launch in the additional states of Illinois, Massachusetts, and Michigan.

1906 is known more for its support of medicinal cannabis research and invests a percentage of its revenue in clinical trials and educating healthcare practitioners. The company also invests in corporate social responsibility, specifically targeting employment opportunities for those formerly incarcerated individuals who have paid the heaviest price for a century of cannabis prohibition.

“Navy Capital’s investment in 1906 reflects our belief that it is one of the best brands in the country,” said Sean Stiefel, a Navy Capital portfolio manager. “We are very impressed with the company whose fast-acting formulations represent the cutting edge of cannabis. Our investment will help 1906 become one of the leading brands in the new adult-use markets of Illinois, Massachusetts, and Michigan.”

The company’s CEO Peter Barsoom is a Wall Street refugee who set his sights on the cannabis industry in 2014. Initially, 1906 targeted the infused chocolate market that focused on delivering products directed at certain moods. The six experiences, Love, Go, Chill, Midnight, Bliss, and Genius are advertised as delivering finely tuned combinations of select cannabis strains, with potent plant medicines, engineered to be the fastest-acting edibles on the market.

According to the company statement, 1906 has just released Drops, pressed tablets (or pills) that represent the new frontier in cannabis medicine. Developed after years of research and testing, Drops are the only pill on the market to combine medicinal cannabis with plant medicines for targeted effects. Like all 1906 products, Drops employ a patented fast-acting technology that uses lipid microencapsulation for rapid onset (under 20 minutes), the fastest technology in the industry.

The company said that 1906 Drops combine highly effective plant medicines with a low dose of THC plus CBD to create a suite of portable, discreet, vegan, and zero-calorie medicinal formulas in a familiar user-friendly format for daily remedies—a swallow-able coated pill.

1906 Founder Peter Barsoom says, “With Drops, cannabis medicine has finally arrived. For far too long, consumers and patients have had to rely on smoking cannabis in order to get fast onset time and specific effects. After years of R&D, we have finally brought a healthier, more effective product to the cannabis marketplace. And for the first time, we’ve introduced a new experience for cognitive enhancement, Genius, which we believe will finally kill the Reagan-era propaganda that cannabis is brain-dulling.”

 

 


Debra BorchardtAugust 7, 2018
shutterstock_256424509-1280x853.jpg

3min00

New York-based cannabis-focused institutional fund Navy Capital Green International Ltd. invested $3 million of equity into  Nevada-based Oasis Cannabis. Oasis is an integrated cannabis producer and retailer in Nevada. It is also a subsidiary of CLS Holdings USA Inc., which operates as Cannabis Life Sciences.

Navy Capital said that it has an extreme interest in the CLS patented extraction and processing technology. According to the company statement, Navy Capital or select others may invest an additional two million with a 15% overallotment for a total of up to $5,750,000 by August 15, 2018.

“We believe CLS Holdings possesses the premier vertically-integrated cannabis business in Nevada and when combined with the company’s opportunities in other major U.S. states and its cutting-edge scientific developments, we expect that CLS quickly will establish itself as one of the top companies in the emerging U.S. cannabis market,” said John Kaden, Managing Partner and Chief Investment Officer of Navy Capital.

With this investment, CLS now has all the funds in place to complete its build-out of its Las Vegas cultivation and production facility. In addition, CLS will utilize a portion of the proceeds to update its existing Oasis Cannabis dispensary location and improve its signage.

Jeff Binder, Chief Executive Officer of CLS, commented, “We look forward to the added value that Navy Capital brings to CLS. It is a terrific corporate development to have an additional partner, of Navy Capital’s stature, and we are excited by the expertise they bring to CLS.”

Oasis Cannabis

Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. The company recently commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products in August 2017.


Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.